ArticleKidney international reports2024

Combined Rituximab and Daratumumab Treatment in Difficult-to-Treat Nephrotic Syndrome Cases.

Andrea Angeletti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.